|Bid||0.00 x 3000|
|Ask||0.00 x 800|
|Day's range||163.30 - 165.76|
|52-week range||133.65 - 179.92|
|Beta (5Y monthly)||0.72|
|PE ratio (TTM)||24.47|
|Forward dividend & yield||4.24 (2.59%)|
|Ex-dividend date||22 Nov 2021|
|1y target est||N/A|
Dr. Ben Weston, Milwaukee COVID-19 Emergency Operations Center Medical Director, talks about the process of approving the COVID-19 vaccine for children and the global fight against COVID-19.
Novavax CEO Stanley Erck joins Yahoo Finance to discuss the company's filing for vaccine authorization in the UK, plans to seek approval from the FDA, and how supply chain disruption has affected the ramp-up of vaccine production.
The healthcare sector is expected to witness substantial earnings growth of 17.5% in the third quarter.